We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $931M
1-Year Est. Return 47.97%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
+$521M
Cap. Flow
+$39M
Cap. Flow %
2.78%
Top 10 Hldgs %
91.03%
Holding
21
New
4
Increased
7
Reduced
10
Closed
–

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$29.4M
2
HLF icon
Herbalife
HLF
+$6.63M
3
GHC icon
Graham Holdings Company
GHC
+$6.15M
4
MDLZ icon
Mondelez International
MDLZ
+$4.3M
5
BNTX icon
BioNTech
BNTX
+$2.07M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$7.3M
2
NEM icon
Newmont
NEM
+$3.93M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.04M
4
IBKR icon
Interactive Brokers
IBKR
+$124K
5
CTVA icon
Corteva
CTVA
+$65.3K

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.49%
2 Financials 18.75%
3 Communication Services 9.81%
4 Consumer Staples 9.76%
5 Healthcare 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
CALL
iShares Russell 2000 ETF
IWM
$77.3B
$334M 23.79%
144,400
+46,000
+47% +$10.3M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$804B
$225M 16.03%
52,300
+42,400
+428% +$17.7M
IWO icon
3
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
$162M 11.55%
519,500
+344,500
+197% +$104M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.22T
$120M 8.56%
983,520
+13,660
+1% +$1.6M
HLF icon
5
Herbalife
HLF
$1.26B
$119M 8.47%
2,253,861
+133,302
+6% +$6.63M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.09T
$118M 8.4%
423,993
-3,711
-0.9% -$1.04M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$80.6B
$65.6M 4.68%
117,469
+58,082
+98% +$29.4M
IBKR icon
8
Interactive Brokers
IBKR
$40.1B
$56M 3.99%
3,408,648
-7,156
-0.2% -$124K
V icon
9
Visa
V
$695B
$41.5M 2.96%
177,440
-31,920
-15% -$7.3M
CTVA icon
10
Corteva
CTVA
$55.1B
$36.5M 2.6%
823,242
-1,414
-0.2% -$65.3K
BNY
11
Bank of New York Mellon
BNY
$104B
$25.5M 1.82%
497,891
-772
-0.2% -$38.6K
STT icon
12
State Street
STT
$50.7B
$22.1M 1.58%
268,574
-406
-0.2% -$34.3K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.18T
$17.5M 1.25%
139,440
-400
-0.3% -$47.7K
BYND icon
14
PUT
Beyond Meat
BYND
$202M
$15.7M 1.12%
+3,333
New +$13.3M
GHC icon
15
Graham Holdings Company
GHC
$4.78B
$14.9M 1.06%
23,493
+9,552
+69% +$6.15M
MO icon
16
Altria Group
MO
$116B
$13.7M 0.98%
287,561
-348
-0.1% -$17.1K
NEM icon
17
Newmont
NEM
$131B
$4.62M 0.33%
72,829
-58,601
-45% -$3.93M
MDLZ icon
18
Mondelez International
MDLZ
$79.5B
$4.36M 0.31%
+69,807
New +$4.3M
MACK
19
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$3.51M 0.25%
548,836
-1,843
-0.3% -$12.2K
BNTX icon
20
BioNTech
BNTX
$24.8B
$2.45M 0.18%
+10,963
New +$2.07M
DBTX
21
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.37M 0.1%
+159,462
New +$1.41M

Similar funds

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Bronte Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bronte Capital Management held 21 positions worth $1.4B, up 59% from $882M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Bronte Capital Management's Q2 2021 filing shows 4 new, 7 increased and 10 reduced positions. Its largest new stake was Mondelez International: 69,807 shares worth $4.36M. The largest sale was Visa, an estimated $7.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 35% a quarter earlier, followed by Financials and Communication Services.

  • Bronte Capital Management's largest Q2 2021 buy was Mondelez International: 69,807 shares worth $4.36M.
  • Bronte Capital Management added most to Regeneron Pharmaceuticals in Q2 2021, an estimated $29.4M increase.
  • Bronte Capital Management's biggest Q2 2021 reduction was Visa, cutting an estimated $7.3M.
  • Bronte Capital Management's ten largest holdings make up 91% of its $1.4B portfolio in Q2 2021.
  • Bronte Capital Management opened 4 new positions and closed 0 in Q2 2021.
  • Bronte Capital Management's portfolio value rose 59% quarter-over-quarter to $1.4B.

Based on Bronte Capital Management's 13F filing for Q2 2021, filed 9 Aug 2021.